HBIO vs PLSE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 12, 2026

HBIO

41.7
AI Score
VS
HBIO Wins

PLSE

33.4
AI Score

Investment Advisor Scores

HBIO

42score
Recommendation
HOLD

PLSE

33score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HBIO PLSE Winner
Revenue 43.48M 835,000 HBIO
Net Income -6.33M -43.24M HBIO
Net Margin -14.6% -5178.2% HBIO
Operating Income -2.15M -44.42M HBIO
ROE -85.4% -43.5% PLSE
ROA -8.3% -37.4% HBIO
Total Assets 76.29M 115.56M PLSE
Cash 6.50M 101.62M PLSE
Current Ratio 1.87 9.63 PLSE
Free Cash Flow -1.45M -33.43M HBIO

Relative Price Performance (Last 90 Days)

HBIO 1M: +20.8% · 3M: +35.5% PLSE 1M: +62.6% · 3M: +97.3%

Current Technical Phase

HBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.3% over 20 days), RSI 71

RSI (14): 71.1 · Price: $7.48

PLSE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (23.9% over 20 days), RSI 80

RSI (14): 80.1 · Price: $50.42

Fundamentals Snapshot

Metric HBIO PLSE
Market Cap
Forward P/E 11.6 -41.4
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.6% 0.0%
Operating Margin 0.0% -58.2%
EPS -2.30 -1.20
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.